Akanokure Pharmaceuticals

Akanocure is a platform-based drug development company focusing on orphan and unmet needs in oncology, infectious diseases, and immunology. Akanocure’s platform is a robust synthetic strategy aiming to populate new chemical spaces via the efficient discovery, optimization, and manufacturing of oral drug-like compounds/macrocycles bearing high degree of diversity and complexity and maximum biological relevance against undruggable targets like PPIs (protein-protein interactions).